Table 2. Treatment groups and the formulation administered to each one.

Administration route:	Oral	Oral	Oral	Oral	Oral	Intramuscular
Groups (n = 5)	I	II	III	IV	V	VI
PBS	X		X
Chitosan NPs *		X
SmRho (solution)			50 µg
SmRho loaded alginate coated chitosan NPs				50 µg		50 µg
SmRho-CpGODN loaded alginate coated chitosan NPs					50 µg+10 µg

^*NPs: Nanoparticles.